What rates 0% for Chalazion under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis)?

Under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis) (DC 6018), a 0% rating for Chalazion requires: Inactive disease without compensable residuals.

What rates 10% for Chalazion under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis)?

Under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis) (DC 6018), a 10% rating for Chalazion requires: Active recurrent chalazion / hordeolum — minimum 10% per the General Rating Formula. 1 or 2 incapacitating episodes requiring treatment in the past 12 months.

What rates 20% for Chalazion under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis)?

Under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis) (DC 6018), a 20% rating for Chalazion requires: 3 or 4 incapacitating episodes per year.

What rates 40% for Chalazion under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis)?

Under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis) (DC 6018), a 40% rating for Chalazion requires: 5 or 6 incapacitating episodes per year.

What rates 60% for Chalazion under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis)?

Under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis) (DC 6018), a 60% rating for Chalazion requires: 7+ incapacitating episodes per year.

What happens during a C&P exam for Chalazion?

Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation. Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

← All Condition Guides

CLAIM RECON INTEL

Chalazion

Q: What are the VA rating percentages for Chalazion?

Chalazion (DC 6018) is rated at 0%, 10%, 20%, 40%, 60% under 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis). Inactive disease without compensable residuals.

Q: What evidence do I need for a Chalazion VA claim?

Key evidence for a Chalazion claim includes: Service treatment records showing injury or complaints; Imaging (X-ray, MRI, CT); Range of motion measurements; Flare-up documentation per Sharp v. Shulkin; Buddy statements describing limitations. All evidence should document both the condition and its impact on daily functioning.

DC 601838 C.F.R. § 4.79

Diagnostic Code

DC 6018

38 C.F.R. § 4.79

Rating Range

0–60%

5 severity tiers

Source

Verified

38 C.F.R. § 4.79

Chalazion is rated by the U.S. Department of Veterans Affairs under DC 6018 of 38 CFR § 4.79, DC 6018 (rated by analogy to chronic conjunctivitis) across 5 severity tiers (0% / 10% / 20% / 40% / 60%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Chronic, sterile, lipogranulomatous inflammation of a meibomian gland in the eyelid, presenting as a painless firm nodule. Different from a stye (hordeolum), which is an acute infection. Recurrent chalazia may require surgical drainage and can be associated with blepharitis or rosacea.

Rating Criteria

Inactive disease without compensable residuals.

10%

Active recurrent chalazion / hordeolum — minimum 10% per the General Rating Formula. 1 or 2 incapacitating episodes requiring treatment in the past 12 months.

20%

3 or 4 incapacitating episodes per year.

40%

5 or 6 incapacitating episodes per year.

60%

7+ incapacitating episodes per year.

03Key Evidence

—Service treatment records showing injury or complaints

—Imaging (X-ray, MRI, CT)

—Range of motion measurements

—Flare-up documentation per Sharp v. Shulkin

—Buddy statements describing limitations

—Prescription history

—Physical therapy records

—Employment impact documentation

04C&P Exam Tips

1Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.

2Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

3Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.

4Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).

5If you use assistive devices (brace, cane), bring them.

6Describe daily activity impact: work, sleep, household tasks.

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.79 (Eye). Source verified 2026-05-17 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.79 on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING